A panel of industry leaders emphasize the importance of early engagement with payers, real-world evidence, and value-based ...

Canalevia-CA1, a canine-specific formulation of crofelemer, Jaguar's novel, oral plant-based drug sustainably harvested from the Croton lechleri tree, is available from multiple leading veterinary ...

Domestic private pharma companies are expecting robust industry legal changes to facilitate future initiatives.

Rising Pharmaceutical Innovation, AI Integration, and Point-of-Care Testing Applications Drive 9.8% CAGR Growth Across Healthcare and Biotechnology ...

World leaders are dismantling global health programs and cutting back foreign aid. Will an extraordinary new medicine be able ...

David W Miller, CEO of Genesis Research Group, discusses how pharma's decade-long development approach is no longer fit for ...

Regulatory science also plays a crucial role in ensuring public trust in these products and facilitating the translation of ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

A look at China's emergence as a hub for novel treatment pursuits—and ways international investors can best capitalize on the favorable research trajectory.

Gut‑hormone incretins (e.g., GLP‑1 agonists) are the fastest growing segment, forecast to expand at a 33.15% CAGR through ...